Belite Bio, Inc (BLTE)

Belite Bio Statistics

Total Valuation

Belite Bio has a market cap or net worth of $2.14 billion. The enterprise value is $1.99 billion.

Market Cap	2.14B
Enterprise Value	1.99B

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, after market close.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Belite Bio has 32.54 million shares outstanding. The number of shares has increased by 8.22% in one year.

Current Share Class	n/a
Shares Outstanding	32.54M
Shares Change (YoY)	+8.22%
Shares Change (QoQ)	+1.98%
Owned by Insiders (%)	1.40%
Owned by Institutions (%)	0.67%
Float	14.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	13.53
P/TBV Ratio	13.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 25.98

Current Ratio	25.98
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-2,359.25

Financial Efficiency

Return on equity (ROE) is -33.43% and return on invested capital (ROIC) is -23.17%.

Return on Equity (ROE)	-33.43%
Return on Assets (ROA)	-22.23%
Return on Invested Capital (ROIC)	-23.17%
Return on Capital Employed (ROCE)	-29.85%
Revenue Per Employee	n/a
Profits Per Employee	-$1.70M
Employee Count	25
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.43% in the last 52 weeks. The beta is -1.49, so Belite Bio's price volatility has been lower than the market average.

Beta (5Y)	-1.49
52-Week Price Change	+33.43%
50-Day Moving Average	61.81
200-Day Moving Average	62.85
Relative Strength Index (RSI)	62.75
Average Volume (20 Days)	62,597

Short Selling Information

Short Interest	174,425
Short Previous Month	166,737
Short % of Shares Out	1.16%
Short % of Float	n/a
Short Ratio (days to cover)	2.41

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-47.19M
Pretax Income	-31.62M
Net Income	-42.55M
EBITDA	-47.01M
EBIT	-47.19M
Earnings Per Share (EPS)	-$1.37

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	n/a
Net Cash	n/a
Net Cash Per Share	n/a
Equity (Book Value)	158.07M
Book Value Per Share	4.86
Working Capital	153.16M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Belite Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-8.22%
Shareholder Yield	-8.22%
Earnings Yield	-1.99%
FCF Yield	n/a

Analyst Forecast

The average price target for Belite Bio is $96.67, which is 46.36% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$96.67
Price Target Difference	46.36%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1